BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 25472580)

  • 1. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
    Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
    Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
    Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
    Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer.
    Liu H; Liu Y; Kong F; Xin W; Li X; Liang H; Jia Y
    J Am Coll Surg; 2015 Aug; 221(2):579-90. PubMed ID: 26077602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma.
    Fei X; Ma Y; Liu X; Meng Z
    Tohoku J Exp Med; 2017 Nov; 243(3):219-226. PubMed ID: 29187705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
    Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
    Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
    Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
    Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
    Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of increased expression of RBM8A in gastric cancer.
    Lv X; Cheng H
    Braz J Med Biol Res; 2020; 53(4):e9290. PubMed ID: 32294703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.
    Xu W; Chen F; Fei X; Yang X; Lu X
    Med Sci Monit; 2018 Oct; 24():7357-7365. PubMed ID: 30319138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of
    Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
    Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
    J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
    Qi H; Wang Y
    Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.